<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01875198</url>
  </required_header>
  <id_info>
    <org_study_id>4-2013-0138</org_study_id>
    <nct_id>NCT01875198</nct_id>
  </id_info>
  <brief_title>Oncologic Impact of Splenectomy-omitting Radical Pancreatectomy in Well-selected Left-sided Pancreatic Cancer</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yonsei University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Yonsei University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      When distal pancreatectomy is carried out for left-sided pancreatic cancer, splenectomy is&#xD;
      usually performed not only for margin-negative resection but also for effective clearance of&#xD;
      the splenic hilar lymph nodes. However, there was no scientific evidence regarding the&#xD;
      justifiability for spleen resection. Considering potential immunological function of the&#xD;
      spleen, the investigators hypothesized that distal pancreatectomy without pancreatectomy for&#xD;
      left-sided pancreatic cancer is superior than Distal pancreatectomy with pancreatectomy in&#xD;
      terms of short-term perioperative outcomes and disease-specific overall survival.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    because of difficulties of enrolling appropriate participants&#xD;
  </why_stopped>
  <start_date>April 2013</start_date>
  <completion_date type="Actual">April 2014</completion_date>
  <primary_completion_date type="Actual">April 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Bleeding amount</measure>
    <time_frame>5 hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>average of pain score</measure>
    <time_frame>admission period(about 5 days)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>time interval to adjuvant treatment</measure>
    <time_frame>admission period(about 5 days)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>postoperative complication</measure>
    <time_frame>admission period(about 5 days)</time_frame>
    <description>(e.g. postoperative pancreatic fistula, delayed gastric emptying, intra-abdominal abscess, postoperative bleeding, wound infection, etc.)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">1</enrollment>
  <condition>Left-sided Pancreatic Cancer</condition>
  <condition>Ductal Adenocarcinoma</condition>
  <arm_group>
    <arm_group_label>RAMPS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Radical Antegrade Modular Pancreatectomy with Splenectomy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>RAMP</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Radical Antegrade Modular Pancreatectomy without splenectomy</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Radical Antegrade Modular Pancreatectomy with Splenectomy</intervention_name>
    <arm_group_label>RAMPS</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Radical Antegrade Modular Pancreatectomy without splenectomy</intervention_name>
    <description>distal pancreatectomy without pancreatectomy</description>
    <arm_group_label>RAMP</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Ductal adenocarcinoma&#xD;
&#xD;
          2. Age ≥20 and ≤80&#xD;
&#xD;
          3. General performance status: the Karnofsky score&gt; 70% or ECOG 0-1&#xD;
&#xD;
          4. Potentially Curative resection&#xD;
&#xD;
          5. Tumor size &lt; 3cm&#xD;
&#xD;
          6. Pancreatic cancer located on neck or body portion&#xD;
&#xD;
          7. No invasion to spleen or spleen hilum&#xD;
&#xD;
          8. No combined resection except Lt. adrenal gland&#xD;
&#xD;
          9. Distance more than 5cm (≥5cm) between tumor lateral margin and spleen hilum&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Unresectable or locally advanced, metastatic case&#xD;
&#xD;
          2. Patients who do not want surgery&#xD;
&#xD;
          3. ASA (American society of anesthesiologists' physical status classification) score: ≥3&#xD;
&#xD;
          4. Patients with drug or alcohol addiction&#xD;
&#xD;
          5. Patients showing low compliance&#xD;
&#xD;
          6. Patients who not want to involve the clinical trial&#xD;
&#xD;
          7. Patients who are unable to read or understand the informed consent, sign a consent&#xD;
             form (eg, mental retardation, blindness, illiteracy, foreign, etc.)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Severance Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>120-752</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <reference>
    <citation>Kim SH, Kang CM, Satoi S, Sho M, Nakamura Y, Lee WJ. Proposal for splenectomy-omitting radical distal pancreatectomy in well-selected left-sided pancreatic cancer: multicenter survey study. J Hepatobiliary Pancreat Sci. 2013 Mar;20(3):375-81. doi: 10.1007/s00534-012-0549-z.</citation>
    <PMID>22911134</PMID>
  </reference>
  <verification_date>November 2016</verification_date>
  <study_first_submitted>May 28, 2013</study_first_submitted>
  <study_first_submitted_qc>June 10, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 11, 2013</study_first_posted>
  <last_update_submitted>November 19, 2016</last_update_submitted>
  <last_update_submitted_qc>November 19, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 22, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Splenectomy;</keyword>
  <keyword>Spleen-preserving</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pancreatic Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

